BRPI0911808A2 - método para preparar um composto, e, composição - Google Patents

método para preparar um composto, e, composição

Info

Publication number
BRPI0911808A2
BRPI0911808A2 BRPI0911808A BRPI0911808A BRPI0911808A2 BR PI0911808 A2 BRPI0911808 A2 BR PI0911808A2 BR PI0911808 A BRPI0911808 A BR PI0911808A BR PI0911808 A BRPI0911808 A BR PI0911808A BR PI0911808 A2 BRPI0911808 A2 BR PI0911808A2
Authority
BR
Brazil
Prior art keywords
preparing
compound
composition
Prior art date
Application number
BRPI0911808A
Other languages
English (en)
Inventor
David John Pittam
Fiona Ruth Kenley
Martin Francis Jones
Matthew Ball
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BRPI0911808A2 publication Critical patent/BRPI0911808A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0911808A 2008-04-28 2009-04-27 método para preparar um composto, e, composição BRPI0911808A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4832908P 2008-04-28 2008-04-28
PCT/GB2009/050424 WO2009133389A1 (en) 2008-04-28 2009-04-27 Methods of preparing substituted heterocycles

Publications (1)

Publication Number Publication Date
BRPI0911808A2 true BRPI0911808A2 (pt) 2016-10-18

Family

ID=40786810

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911808A BRPI0911808A2 (pt) 2008-04-28 2009-04-27 método para preparar um composto, e, composição

Country Status (15)

Country Link
US (1) US20110112144A1 (pt)
EP (1) EP2283012A1 (pt)
JP (1) JP2011518870A (pt)
KR (1) KR20110014613A (pt)
CN (1) CN102119159A (pt)
AR (1) AR071513A1 (pt)
AU (1) AU2009241656A1 (pt)
BR (1) BRPI0911808A2 (pt)
CA (1) CA2722339A1 (pt)
CL (1) CL2009001008A1 (pt)
IL (1) IL208918A0 (pt)
MX (1) MX2010011870A (pt)
RU (1) RU2010147864A (pt)
TW (1) TW200948352A (pt)
WO (1) WO2009133389A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101967141A (zh) * 2010-10-13 2011-02-09 信实生物医药（上海）有限公司 一种Chk蛋白激酶拮抗剂AZD-7762的制备方法
SG11201610500WA (en) 2014-06-17 2017-01-27 Vertex Pharma Method for treating cancer using a combination of chk1 and atr inhibitors
AU2016331955B2 (en) 2015-09-30 2022-07-21 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014881A2 (en) * 2002-08-09 2004-02-19 Astra Zeneca Ab '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5
ATE501138T1 (de) * 2004-01-05 2011-03-15 Astrazeneca Ab Thiophenderivate als chk-1-inhibitoren
WO2005077345A1 (en) * 2004-02-03 2005-08-25 Astrazeneca Ab Compounds for the treatment of gastro-esophageal reflux disease

Also Published As

Publication number Publication date
IL208918A0 (en) 2011-01-31
JP2011518870A (ja) 2011-06-30
US20110112144A1 (en) 2011-05-12
WO2009133389A1 (en) 2009-11-05
TW200948352A (en) 2009-12-01
MX2010011870A (es) 2010-12-20
CL2009001008A1 (es) 2010-08-20
CA2722339A1 (en) 2009-11-05
RU2010147864A (ru) 2012-06-10
EP2283012A1 (en) 2011-02-16
CN102119159A (zh) 2011-07-06
KR20110014613A (ko) 2011-02-11
AR071513A1 (es) 2010-06-23
AU2009241656A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
BRPI0909691A2 (pt) Composto, método para preparar um composto, e, composição farmacêutica
BRPI0906906A2 (pt) Método para preparar um composto e composto
BRPI0912384A2 (pt) composição, e, método para preparar uma composição
BRPI0908092A2 (pt) Edulcorante, método para preparar uma composição edulcorante, e, composição edulcorante
BRPI0917196A2 (pt) método para a preparação de um complexo, e, forma cristalina de um composto.
BRPI0918038A2 (pt) Processos para preparar um composto e um sal, e, composto
BRPI0812999A2 (pt) Método para preparar um composto
BRPI0819568A2 (pt) métodos para a preparação de um composto
BRPI0910910A2 (pt) processo para preparar um composto
BRPI0910911A2 (pt) processo para preparar um composto
BRPI1011888A2 (pt) processo para preparar um composto, e, composição.
BRPI1010775A2 (pt) composição, método para preparar uma composição, e, uso de uma composição.
BR112012000623A2 (pt) composição de emulsão estabilizada, método, e, método para preparar uma composição de emulsão estabilizada
BRPI1014547A2 (pt) composto, e, processo para preparar um composto.
BRPI0911898A2 (pt) processo para preparar compostos, e, composto.
BRPI0909198A2 (pt) composto antifolato, composto, método para preparar um composto antifolato, composição farmacêutica, método para tratar
BR112013008008A2 (pt) composto, composição farmacêutica e processo para preparar um composto
BRPI1012978A2 (pt) composição tópica, método para preparar a mesma, e, uso de um composto
BRPI0918955A2 (pt) preparação sólida, e, método para estabilizar um composto, e para melhorar a dissoulução de um composto
BRPI0923297A2 (pt) Processos para a fabricação de um composto, e para a preparação de um composto imdiazolinona herbicida
BRPI0823031A2 (pt) Conjunto, e , método para fabricar um conjunto
BRPI0921882A2 (pt) processo para fabricar um composto.
BRPI0917345A2 (pt) composição, e, método para produzir uma composição estabilizada.
BRPI1009816A2 (pt) "método para preparar um composto."
BRPI0914924A2 (pt) processo para preparar aminobifenilas, e, composto.

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]